• Indexing List

Indian Journal of Pharmacy and Pharmacology


Pharmacoeco-economic study: A cost variation analysis of AKT drugs available in Indian market


Full Text PDF Share on Facebook Share on Twitter


Article Type : Research Article

Author Details: Archanabahen Archanabahen,Jitendra R. Zaveri*

Volume : 6

Issue : 1

Online ISSN : 2393-9087

Print ISSN : 2393-9079

Article First Page : 6

Article End Page : 10


Abstract

Introduction: The cost of drug play important role in practice of medicine and disease outcome. In Indian market numerous brand available of generic drug. Tuberculosis is curable disease but if proper treatment not taken by patients then lead to development of drug resistance or pulmonary disability. AKT drugs used for the management of tuberculosis.
Objective: To compare and analysed cost variation in AKT drugs with different brand name for same dosage form & same active compound.
Materials and Methods: The price of the drug with same formulation and same strength (Dosage) was review from Indian drug review issue 3, 2017 (IDR) & CIMS (Apr- Jul 2017). Percentage of cost price variation and Cost ratio is analysed.
Result: High percentage of cost variation among first line AKT drugs seen with Ethambutol (474.51%) followed by Isoniazid (432.60%). Least percentage of cost variation seen with streptomycin (1.01%) followed by rifampicin (1.33%). Maximum cost ratio of first line drugs seen with Ethambutol (5.74). Among 2nd line AKT drug Maximum and least percentage of cost variation are seen with levofloxacin 500 mg tablet formulations (1550.84%) and Ofloxacin 400 mg sustained Releases - tablet (1.57%) respectively. Higher percentage of cost variation seen with more manufacture company/ no. of brand.
Conclusion: The wide percentage of cost variation is seen with AKT drugs available in Indian market. Regulation of drug price by concerned agencies and by government is needed. Rational drug prescription with low cost is important for treatment adherence and disease outcome.

Keywords: Pharmacoeconomics, Cost variation, Cost ratio, AKT drugs.

Doi :-https://doi.org/10.18231/2393-9087.2019.0002